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Haematological features in children less than 12 years on 
cotrimoxazole prophylaxis seen in opportunistic infection clinics at 
Harare and Parirenyatwa teaching hospitals
*P MATEVEKE-KUONA, *MF BWAKURA, **J DZANGARE, *1 PAZVAKAVAMBWA 
Abstract
Objective: To determ ine the prevalence o f  peripheral haem atological abnorm alities in  children receiving 
cotrim oxazole prophylaxis.
Design: A n outpatient hospital based  cross sectional study.
Setting: The study w as conducted at tw o tertiary  peadiatric H IV  clinics that offer com prehensive care to 
children living w ith  H I V.
Subjects'. 202 H IV  infected, antiretroviral therapy naive children aged betw een 3 m onths and 12 years w ho 
were receiving cotrim oxazole prophylaxis for at least 1 m onth w ith  m ore than  95%  adherence to  prophylaxis 
w ere included.
Main Outcome Measures: H aem atological abnorm alities on full b lood  count and peripheral film.
Results: The prevalence o f  anaem ia w as 62%  w ith  norm ocytic norm ochrom ic anaem ia being  the m ost 
frequent type (45% ). The com m onest red  b lood  cell abnorm ality  w as rouleaux form ation on  the peripheral 
film. M onocytosis occurred in 62% , leucopaenia in 39% , eosinophilia in 34% , neutropaenia in 18% and 
lym phopaenia in  10% o f  the children.
Conclusion: This study show ed a h igh prevalence o f  haem atological abnorm alities in  H IV  infected  children 
on cotrim oxazole prophylaxis. It em phasizes the need for evaluation for anaem ia and its m anagem ent in 
children on cotrim oxazole prophylaxis.
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Introduction
Paediatric Human immunodeficiency virus (HIV) 
infection has been growing parallel to the adult 
pandemic. Sub-Saharan Africa accounts for more than 
two thirds o f the people living with HIV in the world. 
Approximately 90% of children with HIV infection in 
the world reside in this region. Estimates show that 
more than 145 000 children were living with HIV in 
Zimbabwe in 2010[Ministry o f Health and Child
Welfare, AIDS and TB Unit, Unpublished data]. 
Maternal to child transmission o f HIV accounts for 
more than 95% of infections in children. Opportunistic 
infections (OI) are an important cause o f morbidity and 
mortality in children infected with HTV. These 
infectious complications are critical indicators of 
disease progression.
Cotrimoxazole prophylaxis has been shown to reduce 
morbidity and mortality in HIV infected and exposed 
children .The WHO recommends prophylactic dosing
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with cotrimoxazole for HIV infected and exposed 
children. HIV exposed infants should receive 
cotrimoxazole prophylaxis from 4 to 6 weeks after 
birth until HIV infection has been excluded and the 
mother has stopped breastfeeding. Any child identified 
as HIV infected with clinical signs or symptoms 
suggestive o f HIV should also receive prophylaxis with 
cotrimoxazole. Despite the benefits o f cotrimoxazole, 
it has its own limitations . Cotrimoxazole has been 
shown to cause haematological side effects when given 
as treatment for common infections even for periods 
less than two weeks . This makes it important to study 
the haematological features in children on long term 
cotrimoxazole prophylaxis. Cotrimoxazole is a 
combination o f Trimethoprim and Sulfamethoxazole 
in the ratio o f 1:5. Cotrimoxazole blocks synthesis of 
di-hydrofolic acid. However, it inhibits this process 50 
000 times more in bacteria than human cells. Its 
spectrum o f activity includes respiratory pathogens 
such as streptococcus pneumonia, Hemophilus 
influenza and pneumocystis jiroveci. It also has 
activity against urinary and gastrointestinal pathogens. 
Side effects o f Cotrimoxazole include nausea, 
vom iting, g lossitis, nephrotoxicity, glaucom a, 
dermatological and haematological abnormalities. 
H aem atological side effects o f  TMP include 
megaloblastic anaemia and granulocytopaenia. Side 
effects o f sulfamethoxazole include fever, skin rashes, 
crystalluria, hemolytic or aplastic anaemia, leucopenia, 
and thrombocytopenia. Reports have described 
haem atological abnorm alities in 72% o f HIV 
uninfected children on intravenous trimethoprim- 
sulfamethoxazole short treatment course13 and 48% of 
children on oral combination14. It is not clear how 
c o tr im o x a z o le  p ro p h y la x is  im p ac ts  on the  
haematological profile o f HIV infected children given 
the fact there are several haematological abnormalities 
associated with HIV infection. These include bone 
marrow abnormalities and peripheral cytopaenias: 
a n a e m ia , le u c o p a e n ia ,  ly m p h o p a e n ia  an d  
thrombocytopaenia. Anaemia is the commonest 
haematological abnormality occurring in up to 84% of 
children with HIV. The mechanism o f anaemia is 
multifactorial. Cotrimoxazole may compound the 
haematological effects o f HIV infection.
Many children who are HIV infected or exposed are 
going to be exposed to cotrimoxazole. Some o f the HIV 
exposed children are not infected but, because of 
limited access to early infant diagnosis for children 
before 18 m onths, they w ill be exposed to 
cotrimoxazole prophylaxis. The haematological side 
effects o f cotrimoxazole could potentially worsen the 
haematological effects o f HIV infection. This study 
provides an opportunity to describe the peripheral 
h a e m a to lo g ica l fea tu re s  in c h ild ren  tak in g  
cotrimoxazole prophylaxis.
Materials and Methods
A hospital based cross sectional study was conducted in
Harare the capital city o f Zimbabwe from December 
2007 to May 2008. Patients were recruited from the 
paediatric HIV clinics at Harare Children's Hospital 
and Parirenyatwa Hospital. These clinics were set up to 
provide comprehensive care to HIV infected children. 
Both hospitals are tertiary referral centers and teaching 
hospitals. Children were recruited consecutively to 
achieve a sample size o f 210. Sample size was 
calculated  using an estim ated prevalence o f 
haematological abnormalities that was determined by 
Asmar et al in children who were treated with oral 
cotrimoxazole o f 48 % 14. A desired confidence interval 
of 95% and a margin of error o f 7% were assumed. 
Children between 3 months and 12 years o f age who 
were on oral Cotrimoxazole for at least a month with 
more than 95 % adherence to prophylaxis, and were not 
receiving anti-retroviral treatment were recruited. 
Children who had been hospitalized in the previous 2 
weeks, children who were acutely ill and needed 
hospitalization and children whose date o f birth could 
not be ascertained were excluded from the study.
Demographic and clinical data were obtained through 
administration of a standardized questionnaire and 
physical examination at enrolment. Date o f birth was 
confirmed by double checking with the child health 
card, registration forms at the clinics or birth certificate 
if  available. Duration o f cotrimoxazole prophylaxis 
was confirmed with the children's medical records to 
minimize recall bias. Clinical staging for HIV infection 
using the WHO HIV clinical staging system, 
measurement o f weight, length for children below 2 
years and height were done by a single person to 
minimize inter- observer variation. Height and length 
were measured using a height board. A hanging Salter 
scale model 2356S (manufactured in 2001 England) 
was used to measure weight in children 15kg and under. 
A standing Salter scale model 204948 was used to 
measure weight in children above 15kg. Scales were 
standardized every morning. Weight for height 
indicator was used to define malnutrition and Z scores 
employed to grade malnutrition. Malnutrition was 
defined as weight for height below Z score -2.
Laboratory diagnosis.
Two milliliters o f venous blood were collected once in 
EDTA tubes and sent to a private laboratory within 2 
hours o f collection for a full blood count and peripheral 
film. Specimens were analyzed with Cell-Dyn 3700SL 
manufactured February 2005 in German and the 
peripheral films viewed under a light microscopy after 
Giemsa staining by a haematology technician under the 
supervision o f a haematologist. Laboratory machines 
were calibrated every morning using control samples 
supplied by the manufacturer. Anaemia was defined as 
haemoglobin concentration 2 standard deviations 
below the mean for age. The rest o f definitions used are 
shown in appendix 3.
Ethics.
Written informed consent from care givers and assent
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from children above 7 years were obtained. The study 
protocol was approved by the Ethics committees o f the 
local institutional boards at Harare hospital, the Joint 
Parirenyatwa Hospital and College o f Health Sciences 
Research Ethics Committee and the Medical Research 
Council o f Zimbabwe (MRCZ).
Statistics.
Data analysis was done using the Stata version 10.0 
(Statacort, Texas 77845, USA). The prevalence o f 
anaemia, neutropaenia, thrombocytopaenia and other 
haematological abnormalities detected were calculated 
within 95 % confidence interval. Univariate and 
multiple logistic regressions were used to investigate 
associations between the haematological abnormalities 
with age, sex, duration o f  prophylaxis with 
cotrimoxazole, WHO HIV clinical staging and 
nutritional status. A p-value o f <0.05 was considered 
significant.
Results
A total o f 210 children were recruited into the study and 
of these 8 were excluded from analysis because of 
incomplete data. The demographic characteristics o f 
the children are shown in Table I.
Table I: Baseline characteristics o f the children 
(n=202).
Characteristics
Gender n (%)
Male 88 (44)
Female 114(56)
Age (months)
Median (Ql; Q3) 78 (47; 105)
Height (cm)
Median (Ql; Q3) 109 (90; 120)
Weight (kg)
Median (Ql; Q3) 17 (12.5; 21)
Various haematological abnormalities were detected. 
Prevalence o f anaemia was 62% and most o f the 
anaemic children had normocytic normochromic 
anaemia as shown in Table II.
Table II: Types o f anaemia detected in study 
participants.
Proportion (%)
No anaemia 38
Nomrocytic normochronic anaemia 45
Microcytic anamemia 12
Macrocytic anaemia 5
Total 100
Rouleaux formation was the commonest peripheral
film abnormality in 45% of the children. Other 
abnormalities included anisocytosis, hypochromia, 
anisochromia, polychromasia, poikilocytosis and 
target cells. A longer duration o f taking cotrimoxazole 
prophylaxis seemed protective from anaemia (p = 
0.02).
Table III: White blood cell abnormalities detected in 
study participants.
White cell abnormalities n (%)
Monocystosis 126 (62)
Eosinophilia 69 (34)
Leucopaenia 39(19)
Leucocystosis 12(6)
Neutropaenia 36(18)
Neutrophilia 6(3)
Lymphopaenia 21 (10)
Older children were less likely to have monocytosis (p
0.00).Monocytosis was more prevalent in those with 
advanced stage o f HIV infection (p 0.00). Male 
participants were less likely to have eosinophilia (p 
0.02). Lymphopaenia occurred less in children with 
longer exposure to co trim oxazo le  (p 0.03). 
Leucopaenia, leucocytosis, and neutropaenia, were not 
significantly associated with any o f the patient 
characteristics.
Platelet abnormalities detected.
The prevalence o f thrombocytosis was 14 % and that o f 
t h r o m b o c y t o p a e n i a  w a s  7 %. S e v e r e  
thrombocytopaenia was detected in only 2 children. 
Platelet clumping was noted on the peripheral film in 2 
children. Throm bocytopaenia was significantly 
associated with malnutrition (p 0.04). Thrombocytosis 
was not significantly associated with any o f the 
participants' characteristics.
Discussion
Haematological abnormalities such as anaemia, 
leucopaenia and thrombocytopaenia are associated 
with more rapid progression to AIDS and reduced 
survival . Findings in this study showed a large 
proportion o f  children had anaemia. Normocytic 
normochromic anaemia was the most common type of 
anaemia found. The commonest red cell abnormality 
detected was the presence o f rouleaux on peripheral 
film. Various white cell abnormalities were detected 
with monocytosis being the most frequent.
The prevalence o f anaemia in this study was lower 
than that detected in South Africa20 o f 73% in children 
on c o tr im o x a z o le  p ro p h y la x is . N orm ocy tic  
normochromic anaemia was die commonest type o f 
anaemia and this is similar to the findings in South 
African children. This reflects anaemia o f chronic 
illnesses. Inflammatory cytokines released during HIV 
infection and accompanying opportunistic infections 
inhibit erythropoiesis, blunt the erythropoietin
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response, reduce red blood cell survival and prevent 
release o f iron from the reticuloendothelial system 
resulting in anaemia of chronic illnesses. Macrocytic 
anaemia was present in 5% of the children. This is less 
than the 10% that was reported in HIV infected 
Zimbabwean children who were not on cotrimoxazole 
prophylaxis 17 despite the fact that in the current study 
participants were taking an antifolate drug. Causes of 
macrocytosis include nutritional deficiencies of folate 
and vitamin B12. Presence o f rouleaux was the most 
common red blood cell disorder. Rouleaux formation 
occurs when plasma proteins block the negative charge 
on erythrocytes surface and red cells stack in long 
columns. This is a non-specific finding in many clinical 
conditions especially if  the erythrocyte sedimentation 
rate is raised. Anisocytosis was the second commonest 
abnormality. It is also a non-specific feature that maybe 
present in any red blood cell disorder including iron 
deficiency anaemia and anaemia o f chronic illnesses. 
In South Africa anisocytosis was the commonest RBC 
abnormality with a prevalence o f 68%20. The children 
in the South African study were younger (median age 
25 months) compared to those in the current study who 
had a median age o f 78 months.
Monocytosis (62%) was the commonest white blood 
cell disorder followed by eosinophilia (34%). A report 
on h a e m a t o l o g i c a l  a b n o r m a l i t i e s  p r io r  to 
cotrimoxazole prophylaxis in Zimbabwe showed a 
monocytosis prevalence o f 10% 17. The differences 
between the two studies are in the definition of 
monocytosis and sample size. They used a much higher 
cut off o f lx  109/litre and had a smaller sample size. 
Monocytes are mononuclear phagocytes and have an 
important role in host defenses, tissue repair and 
remodeling. Many pathogens including viruses, 
bacteria, fungi and parasites can induce monocytosis. 
M onocytosis has also been noted to preceed 
neurological symptoms of HIV infection such as 
encephalopathy in children and may be used as 
markers o f neuropathogenicity.
The prevalence of thrombocytosis (14%) was higher 
than that o f thrombocytopaenia (7%). Compared to 
findings in the study by Adewuyi and Chitsike of 
thrombocytopaenia prevalence of 30%17, this study has 
a much lower prevalence despite the fact that children 
a re  on  c o t r i m o x a z o l e  w h i c h  c a n  c a u s e  
thrombocytopaenia. However, reduced infections in 
children on cotrimoxazole prophylaxis could explain 
the difference. In Nigeria a prevalence of only 1% was 
detected, but a cut off of lOOx 109/litre was used which 
would miss patients with mild thrombocytopaenia19. 
The major difference between this study and the studies 
done in Zimbabwe and Nigeria are that age specific 
definitions of the haematological abnormalities were 
employed. The other two studies used blanket 
definitions yet these parameters change with age. 
However, a reference range derived in America was 
used and this is a limitation. Doing a malaria test, 
reticulocyte count, bone marrow biopsy and CD4 count 
would have helped in characterizing the hematological
abnormalities further. Children whose date of birth 
could not be determined were excluded from the study 
and this introduced sampling bias. The HIV clinics 
tended to look after older children. This may be 
because o f challenges in diagnosing HIV infection in 
children below 18 months or that infants infected in 
utero and perinatally have rapidly progressive disease, 
therefore are more likely to die or be on antiretroviral 
therapy which was an exclusion criteria. One cannot 
conclude a causal relationship o f cotrimoxazole and 
haematological findings because this was a cross 
sectional study. In addition, the back ground HIV 
infection is a confounding factor. The normal values 
used  to def ine the var ious  haemato log ica l  
abnormalities are not locally derived hence caution 
should be exercised. Black Africans have been shown 
to have lower leucocyte, neutrophil (benign ethnic 
neutropaenia), and platelet counts compared to 
Caucasians. This is more in males and children younger 
than five years o f age. The explanation is still not clear 
but nutritional and genetic factors are implicated.
Conclusions
A significant number o f children on cotrimoxazole 
prophylaxis had anaemia. The most common type of 
anaemia was normocytic normochromic anaemia. A 
longer duration o f exposure to cotrimoxazole was less 
likely  to be associated  w ith anaem ia. It is 
recommended that a clinical assessment for pallor be 
done at each clinic visit and if  present a full blood count 
should be done in children on cotrimoxazole 
prophylaxis. Detected abnormalities should be treated 
since some cytopaenias such as anaemia are known risk 
factors for mortality in HIV infection.
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